CNS & Neurological Disorders - Drug Targets
Title:Editorial: Combining Forces to Improve Alzheimer’s Disease Drug Discovery: The Symptomatic Battle
Volume: 15 Issue: 7
Author(s): Julie Deguil, Alexandra Auffret, Esther Schenker, Fabienne Aujard, Yves Lamberty, David Bartrès-Faz, Olivier Blin, Joëlle Micallef, Jill C. Richardson and Régis Bordet
Affiliation:
Export Options
About this article
Cite this article as:
Deguil Julie, Auffret Alexandra, Schenker Esther, Aujard Fabienne, Lamberty Yves, Bartrès-Faz David, Blin Olivier, Micallef Joëlle, Richardson C. Jill and Bordet Régis, Editorial: Combining Forces to Improve Alzheimer’s Disease Drug Discovery: The Symptomatic Battle, CNS & Neurological Disorders - Drug Targets 2016; 15 (7) . https://dx.doi.org/10.2174/187152731507160808200737
DOI https://dx.doi.org/10.2174/187152731507160808200737 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
Call for Papers in Thematic Issues
Diagnosis and treatment of central nervous system infectious diseases
Infectious diseases of the central nervous system (CNS) can be divided into bacterial, tuberculous, viral, fungal, parasitic infections, etc. Early etiological treatment is often the most crucial means to reduce the mortality rate of patients with central nervous system infections, reduce complications and sequelae, and improve prognosis. The initial clinical ...read more
Techniques of Drug Repurposing: Delivering a new life to Herbs & Drugs
Of late, with the adaptation of innovative approaches and integration of advancements made towards medical sciences as well as the availability of a wide range of tools; several therapeutic challenges are being translated into viable clinical solutions, with a high degree of efficacy, safety, and selectivity. With a better understanding ...read more
Trends and perspectives in the rational management of CNS disorders
Central nervous system (CNS) diseases enforce a significant global health burden, driving ongoing efforts to improve our understanding and effectiveness of therapy. This issue investigates current advances in the discipline, focusing on the understanding as well as therapeutic handling of various CNS diseases. The issue covers a variety of diseases, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Naturally Occurring NF-κB Inhibitors
Mini-Reviews in Medicinal Chemistry Using Mass Spectrometry-Based Peptidomics to understand the Brain and Disorders such as Parkinson’s Disease and Schizophrenia
Current Topics in Medicinal Chemistry Computer Simulations of Alzheimers Amyloid β-Protein Folding and Assembly
Current Alzheimer Research Small Molecules in Stem Cell Research
Current Pharmaceutical Biotechnology Acamprosate: How, Where, and for Whom Does it Work? Mechanism of Action, Treatment Targets, and Individualized Therapy
Current Pharmaceutical Design Editorial (Thematic Issue: W(e)nt to the Brain: Wnt Signaling in Neurological Disorders)
CNS & Neurological Disorders - Drug Targets Protein Kinase C Modulates Aurora-kinase Inhibition Induced by CCT129202 in HMC-1560,816 Cell Line
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Tumoural Expression of Connective Tissue Growth Factor (CTGF) Impacts on Survival in Patients Diagnosed with Hepatocellular Carcinoma (HCC)
Current Cancer Drug Targets Antioxidant Properties of Pyrimidine and Uracil Derivatives
Current Organic Chemistry Polyphenols: A Potential New Strategy for the Prevention and Treatment of Anxiety and Depression
Current Nutrition & Food Science A Possible Approach for Stem Cell Gene Therapy of Fanconi Anemia
Current Gene Therapy Editorial (Thematic Issue: Oxidative Stress and Alzheimer Disease: Where Do We Stand?)
Current Alzheimer Research Recent Advances in Medicinal Chemistry to Treat Filariasis and Helminthiasis
Current Topics in Medicinal Chemistry Defining the earliest pathological changes of Alzheimer’s disease
Current Alzheimer Research Oxidative Stress During Myocardial Ischaemia and Heart Failure
Current Pharmaceutical Design Docosahexaenoic Acid and Membrane Lipid Domains
Current Organic Chemistry Platelet-Activating Factor (PAF) Antagonists Attenuate Inflammatory- Based Pain: Potential Cellular and Anatomical Sites of PAF Action
Central Nervous System Agents in Medicinal Chemistry Meet Our Editorial Board Member
Current Neuropharmacology Estrogen Regulation of Adipose Tissue Functions: Involvement of Estrogen Receptor Isoforms
Infectious Disorders - Drug Targets Drug-Drug Interactions Associated with Antiplatelet Therapy
Cardiovascular & Hematological Agents in Medicinal Chemistry